Mechanically, regulated by ER signaling in luminal-type breast cancer, SCUBE2 acts in an autocrine manner on cancer cells, leading to Hedgehog signal activation, osteoblast differentiation, and immune suppression-mediated bone metastasis [28]. Here, SCUBE2 is linked to breast cancer.